日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development of vaccines at the time of COVID-19

新冠疫情期间疫苗的研发

Almond, Jeffrey; Hacker, Jörg; Harwood, Colin; Pizza, Mariagrazia; Rappuoli, Rino; Ron, Eliora Z; Sansonetti, Philippe; Vanderslott, Samantha; Wieler, Lothar H

Low doses of flagellin-L2 multimer vaccines protect against challenge with diverse papillomavirus genotypes.

低剂量的鞭毛蛋白-L2多聚体疫苗可保护机体免受多种乳头瘤病毒基因型的攻击

Kalnin Kirill, Tibbitts Timothy, Yan Yanhua, Stegalkina Svetlana, Shen Lihua, Costa Victor, Sabharwal Robert, Anderson Stephen F, Day Patricia M, Christensen Neil, Schiller John T, Jagu Subhashini, Roden Richard B S, Almond Jeffrey, Kleanthous Harold

Cross-serotype immunity induced by immunization with a conserved rhinovirus capsid protein.

用保守的鼻病毒衣壳蛋白进行免疫接种可诱导交叉血清型免疫

Glanville Nicholas, McLean Gary R, Guy Bruno, Lecouturier Valerie, Berry Catherine, Girerd Yves, Gregoire Christophe, Walton Ross P, Pearson Rebecca M, Kebadze Tatiana, Burdin Nicolas, Bartlett Nathan W, Almond Jeffrey W, Johnston Sebastian L

Vaccine production, distribution, access, and uptake

疫苗生产、分发、获取和接种

Smith, Jon; Lipsitch, Marc; Almond, Jeffrey W

Delivery technologies for human vaccines

人类疫苗递送技术

Moingeon, Philippe; de Taisne, Charles; Almond, Jeffrey